GlassScriptPhysician profile
Quoc P Tran
NPI 1457764342
$8,888.29
in general payments reported to CMS, 2019-2025
23 companies · $1,207 in 2025
The $1,207 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $369 · 2021: $2,323 · 2022: $881 · 2023: $268 · 2024: $2,944 · 2025: $1,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,332 · Travel and Lodging: $2,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,332.31 |
| Travel and Lodging | $2,086.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $2,815.47 | 2021-2024 | Ha Minuteman G3-R, Liberty Si |
| Boston Scientific Corporation | $2,504.60 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Nevro Corp. | $1,010.11 | 2019-2024 | Senza |
| Medtronic USA, INC. | $577.67 | 2019 | |
| Curonix LLC | $475.13 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $418.20 | 2022 | |
| Collegium Pharmaceutical, INC. | $219.85 | 2020-2023 | Belbuca |
| Stryker Corporation | $170.32 | 2025 | Mild Device Kit |
| Relievant Medsystems, INC. | $123.68 | 2022 | |
| Mml US, INC. | $86.16 | 2025 | Reactiv8 |
| Medtronic, INC. | $82.71 | 2021-2025 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $68.12 | 2024 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.64 | 2021-2022 | |
| Abbvie INC. | $54.24 | 2024 | |
| Scilex Pharmaceuticals INC. | $41.79 | 2022-2023 | Ztlido |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $36.37 | 2024 | Iovera, Zilretta |
| Stimwave Technologies Incorporated | $30.25 | 2020-2021 | |
| Zyla Life Sciences, INC. | $23.04 | 2020 | |
| Allergan, INC. | $19.30 | 2020 | |
| Globus Medical, INC. | $17.82 | 2025 | Senza |
| Pacira Therapeutics, INC. | $16.66 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $16.66 | 2025 | |
| Spr Therapeutics, INC | $14.50 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quoc Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.